<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Mochida Pharmaceutical Co., Ltd. — News on 6ix</title>
<link>https://6ix.com/company/mochida-pharmaceutical-co-ltd</link>
<description>Latest news and press releases for Mochida Pharmaceutical Co., Ltd. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 15 Dec 2025 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/mochida-pharmaceutical-co-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d62175beedb30cb6fc2bef.webp</url>
<title>Mochida Pharmaceutical Co., Ltd.</title>
<link>https://6ix.com/company/mochida-pharmaceutical-co-ltd</link>
</image>
<item>
<title>Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan</title>
<link>https://6ix.com/company/mochida-pharmaceutical-co-ltd/news/driven-by-a-common-vision-mochida-pharmaceutical-co-ltd-and-duchesnay-inc-sign-a-partnership-to-help-address-the-issue-of-drug-gap-in-japan</link>
<guid isPermaLink="true">https://6ix.com/company/mochida-pharmaceutical-co-ltd/news/driven-by-a-common-vision-mochida-pharmaceutical-co-ltd-and-duchesnay-inc-sign-a-partnership-to-help-address-the-issue-of-drug-gap-in-japan</guid>
<pubDate>Mon, 15 Dec 2025 12:30:00 GMT</pubDate>
<description>Mochida Pharmaceutical Co., Ltd. (Head Office: Shinjuku-ku, Tokyo, Japan; President: Naoyuki Mochida; hereinafter "Mochida") and Duchesnay Inc. (Head Office: Quebec, Canada; President: Éric Gervais; hereinafter "Duchesnay") announce that they have entered into a license agreement to provide access to Bonjesta® (hereinafter "the product") in Japan. Under this agreement, the companies will collaborate closely with the objective of making this product available for women in Japan, with Mochida cond</description>
</item>
</channel>
</rss>